An exhaustive perspective on structural insights of SGLT2 inhibitors: A novel class of antidiabetic agent. Keywords : ['structural insight', 'novel class', 'exhaustive perspective', 'antidiabetic agent', 'inhibitor'] Author : S Bhattacharya 8
An exhaustive perspective on structural insights of SGLT2 inhibitors: A novel class of antidiabetic agent. Keywords : ['structural insight', 'novel class', 'exhaustive perspective', 'antidiabetic agent', 'inhibitor'] Author : S Bhattacharya 8
An exhaustive perspective on structural insights of SGLT2 inhibitors: A novel class of antidiabetic agent. Keywords : ['structural insight', 'novel class', 'exhaustive perspective', 'antidiabetic agent', 'inhibitor'] Author : S Bhattacharya 8
Remogliflozin: the new low cost SGLT-2 inhibitor for type 2 diabetes mellitus. Keywords : ['new low cost inhibitor', 'type diabetes mellitus', 'remogliflozin'] Author : S Atal 8
Remogliflozin: the new low cost SGLT-2 inhibitor for type 2 diabetes mellitus. Keywords : ['new low cost inhibitor', 'type diabetes mellitus', 'remogliflozin'] Author : S Atal 8
Alternate-day add-on therapy with dapagliflozin in patients with type 2 diabetes mellitus: potential benefits and concerns. Keywords : ['type diabete mellitus potential benefit', 'alternateday addon therapy', 'patient', 'dapagliflozin', 'concern'] Author : H Singh 8
Alternate-day add-on therapy with dapagliflozin in patients with type 2 diabetes mellitus: potential benefits and concerns. Keywords : ['type diabete mellitus potential benefit', 'alternateday addon therapy', 'patient', 'dapagliflozin', 'concern'] Author : H Singh 8
Alternate-day add-on therapy with dapagliflozin in patients with type 2 diabetes mellitus: potential benefits and concerns. Keywords : ['type diabete mellitus potential benefit', 'alternateday addon therapy', 'patient', 'dapagliflozin', 'concern'] Author : H Singh 8
Alternate-day add-on therapy with dapagliflozin in patients with type 2 diabetes mellitus: potential benefits and concerns. Keywords : ['type diabete mellitus potential benefit', 'alternateday addon therapy', 'patient', 'dapagliflozin', 'concern'] Author : H Singh 8
Alternate-day add-on therapy with dapagliflozin in patients with type 2 diabetes mellitus: potential benefits and concerns. Keywords : ['type diabete mellitus potential benefit', 'alternateday addon therapy', 'patient', 'dapagliflozin', 'concern'] Author : H Singh 8
